A Potential Immune Therapy for Mesothelioma

Cancer Discov. 2015 Jul;5(7):OF14. doi: 10.1158/2159-8290.CD-NB2015-067. Epub 2015 May 8.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • B7-H1 Antigen / metabolism
  • Clinical Trials, Phase I as Topic
  • Humans
  • Immunotherapy / methods
  • Mesothelioma / drug therapy*
  • Mesothelioma / metabolism
  • Pleural Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • B7-H1 Antigen
  • CD274 protein, human
  • pembrolizumab